SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Senores Pharmaceutic - Quaterly Results

28 Jul 2026 Evaluate
The turnover zoomed to Rs. 269.90 millions, up 67.33% for the June 2026 quarter as against Rs. 161.30 millions during the year-ago period.Net Profit of the company move down -61.85% to Rs. 10.30  millions from Rs. 27.00 millions  in the same quarter last year.The company reported a degrowth in operating Profit to 72.20 millions from 72.30 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 269.90 161.30 67.33 269.90 161.30 67.33 1060.90 385.40 175.27
Other Income 95.50 120.80 -20.94 95.50 120.80 -20.94 663.50 219.90 201.73
PBIDT 72.20 72.30 -0.14 72.20 72.30 -0.14 476.70 147.10 224.07
Interest 22.20 17.60 26.14 22.20 17.60 26.14 69.80 65.20 7.06
PBDT 50.00 54.70 -8.59 50.00 54.70 -8.59 406.90 81.90 396.83
Depreciation 36.10 18.80 92.02 36.10 18.80 92.02 132.30 30.80 329.55
PBT 13.90 35.90 -61.28 13.90 35.90 -61.28 274.60 51.10 437.38
TAX 3.60 8.90 -59.55 3.60 8.90 -59.55 72.10 14.20 407.75
Deferred Tax 0.50 5.00 -90.00 0.50 5.00 -90.00 -12.40 -0.30 4033.33
PAT 10.30 27.00 -61.85 10.30 27.00 -61.85 202.50 36.90 448.78
Equity 460.54 460.54 0.00 460.54 460.54 0.00 460.50 460.50 0.00
PBIDTM(%) 26.75 44.82 -40.32 26.75 44.82 -40.32 44.93 38.17 17.73

Senores Pharmaceutic Share Price

1322.85 -3.45 (-0.26%)
29-Jul-2026 11:21 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1974.70
Dr. Reddys Labs. 1145.15
Cipla 1488.80
Lupin 2450.90
Zydus Lifesciences 1124.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: